Cargando…

Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study

To investigate the significance and impact of molecular subtyping stratification on metastatic breast cancer patients, we identified 159,344 female breast cancer patients in the Surveillance, Epidemiology and End Results (SEER) database with known hormone receptor (HoR) and human epidermal growth fa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gong, Yue, Liu, Yi-Rong, Ji, Peng, Hu, Xin, Shao, Zhi-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5366953/ https://www.ncbi.nlm.nih.gov/pubmed/28345619 http://dx.doi.org/10.1038/srep45411

Ejemplares similares

Clinicopathological Characteristics and Survival Outcomes in Invasive Papillary Carcinoma of the Breast: A SEER Population-Based Study
por: Zheng, Yi-Zi, et al.
Publicado: (2016)

Clinicopathological Characteristics and Survival Outcomes of Invasive Cribriform Carcinoma of Breast: A SEER Population-Based Study
por: Liu, Xi-Yu, et al.
Publicado: (2015)

Prognostic significance of molecular subtype, metastatic site and primary tumor surgery for survival in primary metastatic breast cancer: A SEER-based study
por: Li, Yang, et al.
Publicado: (2021)

Effect of tumor size on breast cancer-specific survival stratified by joint hormone receptor status in a SEER population-based study
por: Zheng, Yi-Zi, et al.
Publicado: (2015)

Breast-Conserving Therapy Versus Mastectomy in Young Breast Cancer Patients Concerning Molecular Subtypes: A SEER Population-Based Study
por: Yu, Ping, et al.
Publicado: (2020)

Epidemiology and survival outcomes of mucinous adenocarcinomas: A SEER population-based study
por: Xie, Guang-Dong, et al.
Publicado: (2018)

Development and Validation of Nomograms for Predicting Overall and Breast Cancer–Specific Survival in Young Women with Breast Cancer: A Population-Based Study
por: Gong, Yue, et al.
Publicado: (2018)

Different prognosis by subtype in the early mucinous breast cancer: a SEER population-based analysis
por: Lian, Weibin, et al.
Publicado: (2020)

Nomogram for predicting preoperative lymph node involvement in patients with invasive micropapillary carcinoma of breast: a SEER population-based study
por: Ye, Fu-Gui, et al.
Publicado: (2018)

Racial/ethnic differences in the outcomes of patients with metastatic breast cancer: contributions of demographic, socioeconomic, tumor and metastatic characteristics
por: Ren, Jin-Xiao, et al.
Publicado: (2018)

Outcomes of patients with inflammatory breast cancer by hormone receptor- and HER2-defined molecular subtypes: A population-based study from the SEER program
por: Li, Juanjuan, et al.
Publicado: (2017)

Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trial
por: Jiang, Yi-Zhou, et al.
Publicado: (2020)

Prognostic disparities in young patients based on breast cancer subtype: A population-based study from the SEER database
por: Chen, Bing, et al.
Publicado: (2023)

Molecular subtypes and precision treatment of triple-negative breast cancer
por: Zhao, Shen, et al.
Publicado: (2020)

Nomograms predicting survival for all four subtypes of breast cancer: a SEER-based population study
por: Chu, Jianli, et al.
Publicado: (2020)

Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer
por: Liu, Yi-Rong, et al.
Publicado: (2016)

Comparison of survival in non-metastatic inflammatory and other T4 breast cancers: a SEER population-based analysis
por: Jiao, Dechuang, et al.
Publicado: (2021)

The Effect of Laterality and Primary Tumor Site on Cancer-Specific Mortality in Breast Cancer: A SEER Population-Based Study
por: Bao, Jing, et al.
Publicado: (2014)

The Prognostic Impact of Age at Diagnosis Upon Breast Cancer of Different Immunohistochemical Subtypes: A Surveillance, Epidemiology, and End Results (SEER) Population-Based Analysis
por: Cai, Shibin, et al.
Publicado: (2020)

Decreased survival in patients with carcinoma of axillary tail versus upper outer quadrant breast cancers: a SEER population-based study
por: Gou, Zong-Chao, et al.
Publicado: (2018)

Association between socioeconomic factors at diagnosis and survival in breast cancer: A population‐based study
por: Ji, Peng, et al.
Publicado: (2020)

SDF-1 expression and tumor-infiltrating lymphocytes identify clinical subtypes of triple-negative breast cancer with different responses to neoadjuvant chemotherapy and survival
por: Wang, Ruo-Xi, et al.
Publicado: (2022)

Uncovering the molecular subtypes of triple-negative breast cancer with a noninvasive radiomic methodology
por: Su, Guan-Hua, et al.
Publicado: (2022)

Effect of nodal status on clinical outcomes of triple-negative breast cancer: a population-based study using the SEER 18 database
por: Wang, Xiao-Xiao, et al.
Publicado: (2016)

Breast Cancer Subtype as a Predictor of Lymph Node Metastasis according to the SEER Registry
por: Mattes, Malcolm D., et al.
Publicado: (2015)

Difference between observed and expected number of involved lymph nodes reflects the metastatic potential of breast cancer independent to intrinsic subtype
por: Yu, Ke-Da, et al.
Publicado: (2015)

Ultrasonographic appearance of triple-negative invasive breast carcinoma is associated with novel molecular subtypes based on transcriptomic analysis
por: Li, Jia-Wei, et al.
Publicado: (2020)

Comparison of patterns and prognosis among distant metastatic breast cancer patients by age groups: a SEER population-based analysis
por: Chen, Meng-Ting, et al.
Publicado: (2017)

Difference in characteristics and outcomes between medullary breast carcinoma and invasive ductal carcinoma: a population based study from SEER 18 database
por: Wang, Xiao-Xiao, et al.
Publicado: (2016)

Breast cancer subtypes predict the preferential site of distant metastases: a SEER based study
por: Wu, Qi, et al.
Publicado: (2017)

In vivo CRISPR screens identify RhoV as a pro‐metastasis factor of triple‐negative breast cancer
por: Jin, Ming‐Liang, et al.
Publicado: (2023)

Breast-conserving Surgery Rates in Breast Cancer Patients With Different Molecular Subtypes: An Observational Study Based on Surveillance, Epidemiology, and End Results (SEER) Database
por: Chen, Kai, et al.
Publicado: (2016)

Impact of surgery on survival in breast cancer with bone metastases only: a SEER database retrospective analysis
por: Peng, Pai, et al.
Publicado: (2021)

The 3′UTR signature defines a highly metastatic subgroup of triple-negative breast cancer
por: Wang, Lei, et al.
Publicado: (2016)

The different outcomes between breast-conserving surgery and mastectomy in triple-negative breast cancer: a population-based study from the SEER 18 database
por: Chen, Qing-Xia, et al.
Publicado: (2016)

Incidence proportions and prognosis of breast cancer patients with bone metastases at initial diagnosis
por: Gong, Yue, et al.
Publicado: (2018)

The impact of young age at diagnosis (age <40 years) on prognosis varies by breast cancer subtype: A U.S. SEER database analysis
por: Kim, Hee Jeong, et al.
Publicado: (2021)

Impact of Marital Status on Prognosis of Patients With Invasive Breast Cancer: A Population-Based Study Using SEER Database
por: Jiao, Dechuang, et al.
Publicado: (2022)

Model-based inference of metastatic seeding rates in de novo metastatic breast cancer reveals the impact of secondary seeding and molecular subtype
por: Vitos, Noemi, et al.
Publicado: (2022)

De novo metastatic breast cancer: Subgroup analysis of molecular subtypes and prognosis
por: Zhang, Li, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dkiej7g70gk81kpo1fdp0d8ia1